Hodson R. Alzheimer’s disease. Nature. 2018;559:S1. https://doi.org/10.1038/d41586-018-05717-6

Article  ADS  CAS  PubMed  Google Scholar 

Simon L, Chloé B, Wendy W. World Alzheimer Report 2023: Reducing dementia risk: never too early, never too late. London, England: Alzheimer’s Disease International; 2023. https://www.alzint.org/u/World-Alzheimer-Report-2023

Google Scholar 

Sang Z, Wang K, Dong J, Tang L. Alzheimer’s disease: Updated multi-targets therapeutics are in clinical and in progress. Eur J Med Chem. 2022;238:114464. https://doi.org/10.1016/j.ejmech.2022.114464

Article  CAS  PubMed  Google Scholar 

Tatulian SA. Challenges and hopes for Alzheimer’s disease. Drug Discov Today. 2022;27:1027–43. https://doi.org/10.1016/j.drudis.2022.01.016

Article  PubMed  Google Scholar 

Kumar B, Thakur A, Dwivedi AR, Kumar R, Kumar V. Multi-target-directed ligands as an effective strategy for the treatment of Alzheimer’s disease. Curr Med Chem. 2022;29:1757–803. https://doi.org/10.2174/0929867328666210512005508

Article  CAS  PubMed  Google Scholar 

Sharma P, Singh M. An ongoing journey of chalcone analogues as single and multi-target ligands in the field of Alzheimer’s disease: A review with structural aspects. Life Sci. 2023;320:121568. https://doi.org/10.1016/j.lfs.2023.121568

Article  CAS  PubMed  Google Scholar 

Teli P, Sahiba N, Soni J, Sethiya A, Agarwal DK, Agarwal S. Exploration of potent multi-target-directed-ligands as anti-alzheimer’s disease agents: A moiety based review. Mini Rev Med Chem. 2021;21:3219–48. https://doi.org/10.2174/1389557521666210304111754

Article  CAS  PubMed  Google Scholar 

Monteiro F, Sotiropoulos I, Carvalho Ó, Sousa N, Silva FS. Multi-mechanical waves against Alzheimer’s disease pathology: a systematic review. Transl Neurodegener. 2021;10:36. https://doi.org/10.1186/s40035-021-00256-z

Article  PubMed  PubMed Central  Google Scholar 

Hardy JA, Higgins GA. Alzheimer’s disease: the amyloid cascade hypothesis. Science. 1992;256:184–5. https://doi.org/10.1126/science.1566067

Article  ADS  CAS  PubMed  Google Scholar 

Fedele E. Anti-amyloid therapies for Alzheimer’s disease and the amyloid cascade hypothesis. Int J Mol Sci. 2023;24:14499. https://doi.org/10.3390/ijms241914499

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhang Y, Chen H, Li R, Sterling K, Song W. Amyloid β-based therapy for Alzheimer’s disease: challenges, successes and future. Signal Transduct Target Ther. 2023;8:248. https://doi.org/10.1038/s41392-023-01484-7

Article  CAS  PubMed  PubMed Central  Google Scholar 

Manzoor S, Hoda N. A comprehensive review of monoamine oxidase inhibitors as anti-Alzheimer’s disease agents: A review. Eur J Med Chem. 2020;206:112787. https://doi.org/10.1016/j.ejmech.2020.112787

Article  CAS  PubMed  Google Scholar 

Ramsay RR. Molecular aspects of monoamine oxidase B. Prog Neuropsychopharmacol Biol Psychiatry. 2016;69:81–89. https://doi.org/10.1016/j.pnpbp.2016.02.005

Article  CAS  PubMed  Google Scholar 

Tripathi AC, Upadhyay S, Paliwal S, Saraf SK. Privileged scaffolds as MAO inhibitors: Retrospect and prospects. Eur J Med Chem. 2018;145:445–97. https://doi.org/10.1016/j.ejmech.2018.01.003

Article  CAS  PubMed  Google Scholar 

Schedin-Weiss S, Inoue M, Hromadkova L, Teranishi Y, Yamamoto NG, Wiehager B, et al. Monoamine oxidase B is elevated in Alzheimer disease neurons, is associated with γ-secretase and regulates neuronal amyloid β-peptide levels. Alzheimers Res Ther. 2017;9:57. https://doi.org/10.1186/s13195-017-0279-1

Article  CAS  PubMed  PubMed Central  Google Scholar 

Matthews DC, Ritter A, Thomas RG, Andrews RD, Lukic AS, Revta C, et al. Rasagiline effects on glucose metabolism, cognition, and tau in Alzheimer’s dementia. Alzheimers Dement (N Y). 2021;7:e12106. https://doi.org/10.1002/trc2.12106

Article  PubMed  Google Scholar 

Birks J, Flicker L. Selegiline for Alzheimer’s disease. Cochrane Database Syst Rev. 2003; CD000442. https://doi.org/10.1002/14651858.CD000442

Tolbert SR, Fuller MA. Selegiline in treatment of behavioral and cognitive symptoms of Alzheimer disease. Ann Pharmacother. 1996;30:1122–9. https://doi.org/10.1177/106002809603001012

Article  CAS  PubMed  Google Scholar 

Thapa P, Upadhyay SP, Suo WZ, Singh V, Gurung P, Lee ES, et al. Chalcone and its analogs: Therapeutic and diagnostic applications in Alzheimer’s disease. Bioorg Chem. 2021;108:104681. https://doi.org/10.1016/j.bioorg.2021.104681

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhang X, Rakesh KP, Bukhari SNA, Balakrishna M, Manukumar HM, Qin HL. Multi-targetable chalcone analogs to treat deadly Alzheimer’s disease: Current view and upcoming advice. Bioorg Chem. 2018;80:86–93. https://doi.org/10.1016/j.bioorg.2018.06.009

Article  CAS  PubMed  Google Scholar 

Krishna A, Kumar S, Sudevan ST, Singh AK, Pappachen LK, Rangarajan TM, et al. A comprehensive review of the docking studies of chalcone for the development of selective MAO-B inhibitors. CNS Neurol Disord Drug Targets. 2023 https://doi.org/10.2174/1871527322666230515155000.

Özdemir Z, Alagöz MA, Bahçecioğlu ÖF, Gök S. Monoamine oxidase-B (MAO-B) inhibitors in the treatment of Alzheimer’s and Parkinson’s disease. Curr Med Chem. 2021;28:6045–65. https://doi.org/10.2174/0929867328666210203204710

Article  CAS  PubMed  Google Scholar 

Zhuang C, Zhang W, Sheng C, Zhang W, Xing C, Miao Z. Chalcone: a privileged structure in medicinal chemistry. Chem Rev. 2017;117:7762–810. https://doi.org/10.1021/acs.chemrev.7b00020

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang K, Yu L, Shi J, Liu W, Sang Z. Multifunctional indanone–chalcone hybrid compounds with anti-β-amyloid (Aβ) aggregation, monoamine oxidase B (MAO-B) inhibition and neuroprotective properties against Alzheimer’s disease. Med Chem Res. 2019;28:1912–22. https://doi.org/10.1007/s00044-019-02423-4

Article  CAS  Google Scholar 

Sang Z, Wang K, Zhang P, Shi J, Liu W, Tan Z. Design, synthesis, in-silico and biological evaluation of novel chalcone derivatives as multi-function agents for the treatment of Alzheimer’s disease. Eur J Med Chem. 2019;180:238–52. https://doi.org/10.1016/j.ejmech.2019.07.021

Article  CAS  PubMed  Google Scholar 

Sang Z, Song Q, Cao Z, Deng Y, Tan Z, Zhang L. Design, synthesis and evaluation of novel dimethylamino chalcone-O-alkylamines derivatives as potential multifunctional agents against Alzheimer’s disease. Eur J Med Chem. 2021;216:113310. https://doi.org/10.1016/j.ejmech.2021.113310

Article  CAS  PubMed  Google Scholar 

Zhou Y, He Y, Teng X, Mi J, Yang J, Wei R, et al. Development of novel salicylic acid-donepezil-rivastigmine hybrids as multifunctional agents for the treatment of Alzheimer’s disease. J Enzyme Inhib Med Chem. 2023;38:2231661. https://doi.org/10.1080/14756366.2023.2231661

Article  CAS  PubMed  PubMed Central  Google Scholar